Literature DB >> 23578393

Reward and aversion in a heterogeneous midbrain dopamine system.

Stephan Lammel1, Byung Kook Lim, Robert C Malenka.   

Abstract

The ventral tegmental area (VTA) is a heterogeneous brain structure that serves a central role in motivation and reward processing. Abnormalities in the function of VTA dopamine (DA) neurons and the targets they influence are implicated in several prominent neuropsychiatric disorders including addiction and depression. Recent studies suggest that the midbrain DA system is composed of anatomically and functionally heterogeneous DA subpopulations with different axonal projections. These findings may explain a number of previously confusing observations that suggested a role for DA in processing both rewarding as well as aversive events. Here we will focus on recent advances in understanding the neural circuits mediating reward and aversion in the VTA and how stress as well as drugs of abuse, in particular cocaine, alter circuit function within a heterogeneous midbrain DA system. This article is part of a Special Issue entitled 'NIDA 40th Anniversary Issue'.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AADC; AMPAR; ATP sensitive potassium channel; Aversion; BLA; CLi; CM; ChR2; D2R; DA; DAT; Dopamine; GAD; IF; IPN; KATP; LDT; LHb; MSN; MT; Mesocortical; Mesolimbic; N-methyl-d-aspartate; NAc; NMDAR; PBP; PFC; PN; RLi; RMTg; RRF; Reward; SN; SNc; SNr; TH; VGluT2; VMAT2; VTA; Ventral tegmental area; amino acid decarboxylase; basolateral amygdala; caudal linear nucleus; channelrhodopsin 2; dopamine; dopamine D2 receptor; dopamine transporter; fasciculus retroflexus; fr; glutamic acid decarboxylase; interfascicular nucleus; interpeduncular nucleus; lVTA; lateral VTA; lateral habenula; laterodorsal tegmentum; mVTA; mammillary body; medial VTA; medial lemniscus; medial terminal nucleus of the accessory optical tract; medium spiny neuron; ml; nucleus accumbens; parabrachial pigmented nucleus; paranigral nucleus; prefrontal cortex; retrorubral field; rostral linear nucleus of the raphe; rostromedial tegmental nucleus; substantia nigra; substantia nigra pars reticulata; substantia nirgra pars compacta; tyrosine hydroxylase; ventral tegmental area; vesicular glutamate transporter 2; vesicular monoamine transporter 2; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor

Mesh:

Substances:

Year:  2013        PMID: 23578393      PMCID: PMC3778102          DOI: 10.1016/j.neuropharm.2013.03.019

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  126 in total

1.  Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats.

Authors:  Stephanie L Borgland; Robert C Malenka; Antonello Bonci
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

2.  Cocaine must enter the brain to evoke unconditioned dopamine release within the nucleus accumbens shell.

Authors:  Kirsten A Porter-Stransky; Seth A Wescott; Molly Hershman; Aneesha Badrinarayan; Caitlin M Vander Weele; Vedran Lovic; Brandon J Aragona
Journal:  Neurosci Lett       Date:  2011-08-24       Impact factor: 3.046

3.  Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons.

Authors:  Garret D Stuber; Marianne Klanker; Bram de Ridder; M Scott Bowers; Ruud N Joosten; Matthijs G Feenstra; Antonello Bonci
Journal:  Science       Date:  2008-09-19       Impact factor: 47.728

4.  Increased phasic activity of VTA dopamine neurons in mice 3 weeks after repeated social defeat.

Authors:  Maria Razzoli; Michela Andreoli; Francesca Michielin; Davide Quarta; David M Sokal
Journal:  Behav Brain Res       Date:  2010-12-01       Impact factor: 3.332

Review 5.  From glutamate co-release to vesicular synergy: vesicular glutamate transporters.

Authors:  Salah El Mestikawy; Asa Wallén-Mackenzie; Guillaume M Fortin; Laurent Descarries; Louis-Eric Trudeau
Journal:  Nat Rev Neurosci       Date:  2011-04       Impact factor: 34.870

6.  Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo.

Authors:  Thomas S Hnasko; Nao Chuhma; Hui Zhang; Germaine Y Goh; David Sulzer; Richard D Palmiter; Stephen Rayport; Robert H Edwards
Journal:  Neuron       Date:  2010-03-11       Impact factor: 17.173

7.  Dopaminergic axons in different divisions of the adult rat striatal complex do not express vesicular glutamate transporters.

Authors:  Jonathan Moss; Mark A Ungless; J Paul Bolam
Journal:  Eur J Neurosci       Date:  2011-03-07       Impact factor: 3.386

8.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

Review 9.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

10.  K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration.

Authors:  Julia Schiemann; Falk Schlaudraff; Verena Klose; Markus Bingmer; Susumu Seino; Peter J Magill; Kareem A Zaghloul; Gaby Schneider; Birgit Liss; Jochen Roeper
Journal:  Nat Neurosci       Date:  2012-08-19       Impact factor: 24.884

View more
  266 in total

Review 1.  Dopamine tunes prefrontal outputs to orchestrate aversive processing.

Authors:  Caitlin M Vander Weele; Cody A Siciliano; Kay M Tye
Journal:  Brain Res       Date:  2018-12-01       Impact factor: 3.252

Review 2.  Contemporary approaches to neural circuit manipulation and mapping: focus on reward and addiction.

Authors:  Benjamin T Saunders; Jocelyn M Richard; Patricia H Janak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

Review 3.  Architectural Representation of Valence in the Limbic System.

Authors:  Praneeth Namburi; Ream Al-Hasani; Gwendolyn G Calhoon; Michael R Bruchas; Kay M Tye
Journal:  Neuropsychopharmacology       Date:  2015-12-09       Impact factor: 7.853

Review 4.  Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders.

Authors:  Sergi Ferré
Journal:  Psychopharmacology (Berl)       Date:  2016-01-20       Impact factor: 4.530

5.  In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward.

Authors:  Erin S Calipari; Rosemary C Bagot; Immanuel Purushothaman; Thomas J Davidson; Jordan T Yorgason; Catherine J Peña; Deena M Walker; Stephen T Pirpinias; Kevin G Guise; Charu Ramakrishnan; Karl Deisseroth; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

6.  Coordinated and Compartmentalized Neuromodulation Shapes Sensory Processing in Drosophila.

Authors:  Raphael Cohn; Ianessa Morantte; Vanessa Ruta
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

7.  Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Authors:  Maria Scherma; Christian Dessì; Anna Lisa Muntoni; Salvatore Lecca; Valentina Satta; Antonio Luchicchi; Marco Pistis; Leigh V Panlilio; Liana Fattore; Steven R Goldberg; Walter Fratta; Paola Fadda
Journal:  Neuropsychopharmacology       Date:  2015-09-21       Impact factor: 7.853

Review 8.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 9.  A role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.

Authors:  Jennifer M Wenzel; Noah A Rauscher; Joseph F Cheer; Erik B Oleson
Journal:  ACS Chem Neurosci       Date:  2014-12-24       Impact factor: 4.418

Review 10.  Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.

Authors:  Nao Chuhma; Susana Mingote; Abigail Kalmbach; Leora Yetnikoff; Stephen Rayport
Journal:  Biol Psychiatry       Date:  2016-07-12       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.